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Sarcoidosis is a systemic granulomatous disease of unknown aetiology characterised by the appearance of noncaseifying epi-
thelioid granulomas in the affected organs, most commonly the lungs, skin, and eyes (Iannuzzi et al. 2007). Necrotizing Sarcoid
Granulomatosis (NGS) is a rare and little-known form of disease, which also presents nodular lung lesions, and it shares
pathologic and clinical findings with sarcoidosis, where the presence of necrosis may lead to misdiagnosis of tuberculosis (TB),
leading to a consequent delay in treatment of the underlying entity (Chong et al. 2015).,is is exactly what happened with the two
cases that we present here.
1. Case Presentation
Case 1 was a 24-year-old woman who was 37 weeks preg-
nant, referred to our Internal Medicine unit because of a
deep supraclavicular lymphadenopathy on the left side
whose fine needle aspiration biopsy (FNAB) revealed
granulomas with necrosis. Case 2 was a 31-year-old male
with neurological symptoms (bradypsychia, peripheral
vertigo, weakness in right lower limb, instability, and
sphincter incontinence), whose cerebral nuclear magnetic
resonance (NMR) revealed the presence of meningeal up-
take; chest tomography scan (CT) showed mediastinal
nodules and bilateral bronchoalveolar infiltrates; and the
open lung biopsy showed sarcoid-like granulomas with
extensive necrosis. Both patients received initially standard
antituberculous treatment, but due to lack of response, the
possibility of a necrotizing sarcoid granulomatosis raised up.
After the start of treatment with glucocorticoids, the
evolution was favourable in both cases. Table 1 provides
more details of these cases.
2. Discussion
Necrotizing sarcoid granulomatosis was first described in
1973 by Liebow, who noted the histological presence of
confluent epithelioid granulomas with small central necrosis
foci or more extensive necrosis, as well as vasculitis [1].
Liebow diferentiated this granulomatous disease from other
forms of noninfectious pulmonary angiitis and gran-
ulomatosis: Wegener’s granulomatosis, Churg–Strauss syn-
drome, bronchocentric granulomatosis, and lymphomatoid
granulomatosis. Actually most authors consider the entity as a
form of sarcoidosis more than a distinct entity, differing in the
fact that there is more intense necrosis and vasculitis [2].
Clinically, very few differences have been described between
the two variants: classical and necrotizing, with pulmonary
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involvement predominating in both. Table 2 provides more
detail on differences between them. In case 1, the clinical
manifestation was a supraclavicular lymphadenopathy; pe-
ripheral lymphadenopathy appears in 40% of sarcoidosis pa-
tients. It should be noted that the presence of intrathoracic
lymphadenopathies is more frequent in the classic form (85%)
than in the necrotizing form (33%). In case 2, the predominant
manifestation was central nervous system (CNS) involvement,
which appears in 5.78% of NGS patients [3] and in the same
proportion in patients with the classic form [4].
In respect of tuberculosis, the most frequent clinical
presentation is also pulmonary involvement. ,e most
frequent extrapulmonary form is lymph node tuberculosis,
which is responsible for 43% of peripheral lymphade-
nopathies in the developed world [6]; CNS involvement is
rarer (5.5%); due to this, it requires haematogenous dis-
semination either from a distal focus or during dissemi-
nated TB [7].
Correct diagnosis is vital because of the different treatments
for the pathologies. Necrotizing sarcoidosis has a good re-
sponse to corticoids, becoming benign [2, 5], and exceptionally
severe neural involvement leading to death has been reported
[3]. In contrast, tuberculosis disease requires TB treatment over
a period of time that depends on the area affected [7].
Given the low effectiveness of cultures from most
extrapulmonary locations for studying extrapulmonary tu-
berculosis, biopsy may be required for diagnosis. Visualising
granulomas with caseification necrosis in biopsy samples,
together with a compatible medical history, is practically
diagnostic. Even so, samples should always be processed for
microbiological study (staining, PCR, and culturing). A lack
of microbiological isolation in the samples should therefore
lead us to suspect a different granulomatous disease, such as
necrotizing sarcoid granulomatosis [8].
Similarly, in patients suspected of having an active tu-
berculosis infection (based on clinical radiological findings),
it is recommended to initiate the antituberculous regimen
prior to microbiological isolation and evaluate the response
after 2-3 weeks, while the microbiological results are being
prepared. If there are no clinical or radiological changes and
Table 1: Clinical characteristic of the two patients with necrotizing sarcoid granulomatosis. SACE: serum angiotensin-converting enzyme;
ACE: angiotensin-converting enzyme; ADA: adenosine deaminase; PCR: polymerase chain reaction; BAL: bronchoalveolar lavage; AFB:
acid-fastness; CT: tomography scan; EEG: electroencephalography; NMR: nuclear magnetic resonance; and FNAB: fine needle aspiration
biopsy.
Case 1 Case 2
Sex and age 24-year-old female. 37 weeks pregnant 31-year-old male
Family history Father diagnosed with discoid lupus Brother diagnosed with sarcoidosis (pulmonary andcutaneous involvement)
Presentation Left supraclavicular lymphadenopathy Peripheral vertigo, weakness in right lower limb, instability,and sphincter incontinence
Physical
examination
Approx. 4× 4 cm supraclavicular tumour attached to deep
planes
Bradipsychia. Right horizontal nystagmus. Paresis 4+/5 left
upper limb and lower limbs. Left extensor cutaneous
plantar reflex. Unstable romberg
Laboratory
No lymphopoenia. T CD4/CD8 lymphocyte ratio: 1.43.
Normal SACE. Calcium/phosphorus metabolism: normal.
24 h urine calciuria slightly higher than normal
(264mg/dL).
Positive Mantoux.
Discrete lymphopoenia. T CD4/CD8 lymphocyte ratio:
0.97. High SACE. Calcium/phosphorus metabolism:
normal. Calciuria in urine at 24 h: normal.
Positive Mantoux.
Lumbar puncture: High ACE and ADA.
Cultures (including fungi) and indian ink: negative.
Sputum culture and mycobacterial PCR: negative.
BAL and sputum samples: negative for AFB
Imaging tests
Cervical CT scan, lymphadenitis that does not suggest
pyogenic origin.
Chest x-ray: normal.
EEG: delta activity, more frequent on the right side.
Brain NMR: meningeal uptake that extends to the cervical
area.
Chest CT scan: mediastinal nodules and bronchoalveolar
infiltrates in both bases
Anatomical
pathology
FNAB supraclavicular adenopathy: necrosis and
granulomas. PCR mycobacterium tuberculosis: negative.
Ganglion exeresis: chronic lymphadenitis with sarcoid
granulomas (Figure 1)
Open lung biopsy: necrotizing granulomatous infiltrates.
PCR mycobacterium tuberculosis: negative
Figure 1: Histopathology of the supraclavicular ganglion exeresis
(case 1). Nodular granulomatosis with extensive necrosis replacing
the normal tissue architecture (haematoxilina-eosina, magnified ×4).
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Table 2: Characteristics of classical variant (nodular sarcoidosis) and necrotizing variant (NGS) [2, 5].
Nodular sarcoidosis Necrotizing variant
Epidemiology








Histology Nonnecrotizing epithelioid granulomas
Granulomas




Pulmonary and/or systemic symptoms (fever, weight
loss, night sweats, malaise, and so on)
84%
Pulmonary and/or systemic symptons (fever, weight
loss, night sweats, malaise, and so on)
Involved organs
>>SACE elevation 17% 4%
>>Eye involvement 14% 12%
>>Skin involvement 10% 2%
>>Lymphadenopathy 9% 0.5%
>>Liver involvement 9% 1%
>>Erithema nodosum 3% 1%
>>Sjögren or sicca
syndrome 1% 3%
>>CNS involvement 2% 7%
>>Neuropathy 0% 2%




Transbronchial lung biopsy (35%)
Tissue obtained by surgical procedures (33%)
Needle biopsy (9%)
Bronchial biopsy (2%)
Intrathoracic lymph node biopsy (8%)
Extrathoracic lymph node biopsy (3%)
Tissue obtained by surgical procedures (98%)
SACE: serum angiotensin converting enzyme; CNS: central nervous system.
Table 3: Main differential diagnosis of NGS and their typical characteristics. GPA: granulomatosis with polyangiitis; FSGS: focal segmental
glomerulosclerosis; EGPA: eosinophilic granulomatosis with polyangiitis; TB: tuberculosis; NTM: nontuberculous mycobacteria; BAL:
bronchoalveolar lavage; ANCA: antineutrophil cytoplasmic antibodies; CRP: C-reactive protein; SIADH: syndrome of inappropriate
antidiuretic hormone secretion; TC: computed tomography; and AFB: acid-fast bacilli.
GPA EGPA TB NTM
Epydemiology
Mean age at diagnosis:
40–60 years
No gender predominance
Mean age at diagnosis:
40 years
No gender predominance
100 per 100,000 or higher:
Sub-Saharan Africa, India,
and the islands of Southeast
Asia and Micronesia
26 to 100 cases per 100,000:
China, central and South
America, Eastern Europe,
and northern Africa





in soil and water, having been
isolated from the domestic
water distribution network,










An eosinophilic, giant cell
vasculitis, especially of the




giant cells, and lymphocytes
Granulomatous
inflammation
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the microbiological study is negative, steroid therapy can be
started [8].
In the two cases presented here, TB treatment was
initiated. Given the absence of a favourable response, it was
performed a biopsy that led to the diagnosis, allowing
corticoid treatment to be initiated. In both patients, good
disease control was achieved with low doses of corticoids,
combined with methotrexate in case 2, permitting rapid
reduction in prednisone doses.
3. Conclusion
Necrotizing sarcoid granulomatosis should be considered
within the differential diagnosis of granulomatous diseases
(Table 3), and knowledge of this variant is essential in order
not to rule out sarcoidosis due to the presence of necrosis.,e
extended duration of the disease, its glucocorticoid response,
negative cultures, and lack of response to TB treatment make
it less likely for the aetiology to be infectious [8].
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Table 3: Continued.




(fever, malaise, anorexia, and
weight loss)






discharge, oral and/or nasal
ulcers, and polychondritis)
Tracheal and pulmonary




and lung disease (migratory
infiltrates, pleural effusion,
nodules rarely cavitary, and
alveolar hemorrhage)






(fever, malaise, and weight
loss)
Primary disease: pleuritic
chest pain, fatigue, cough,
arthralgia, and pharyngitis
Persistent fever, night sweats,












BAL: high percentage of




associated with the SIADH
Elevated acute phase
reactants
Diagnosis Biopsy of a site of suspectedactive disease Surgical lung biopsy
Radiographic imaging







or isolated from at least one
bronchial wash in a
symptomatic patient
Culture of blood for
mycobacteria
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